Pharmaceutical Technology

FEBRUARY 10, 2023

This is not the first treatment to come with a high price tag. Countries with a high willingness for performance-based models, such as the UK, saw this RSA type peak in 2019 before continually declining. Undoubtedly, this has played a factor in the success of market-leading PD-1 inhibitors, Merck & Co.’s

Marketing 105

Marketing Medicine Leads Safety 105

pharmaphorum

JANUARY 9, 2023

Novartis’ programme providing free access to its spinal muscular atrophy (SMA) gene therapy Zolgensma is being scaled back to a dozen countries worldwide, according to the company. ” Zolgensma is one of the most expensive therapies available, with a price tag of around $2.1 Pause in UK access.

Side effects 112

Side effects Patients Management Marketing 112

Pharmaceutical Technology

JULY 14, 2022

The commercial investment required to research and develop an innovative drug, prove its safety and efficacy, and bring it to market is staggering. Go-to-market strategies. The challenge of providing adequate access to the peripheral EU markets is quite evident. Efforts have been made to change this.

Medicine 59

Medicine Marketing Specialization Pharma 59

Pharmaceutical Technology

DECEMBER 5, 2022

Collectively, cannabinoid receptors (CB1 and CB2) are currently the most popular targets in preclinical stage of development, with 391 drugs tagged in total. In the US, the world’s largest pharmaceutical market, most states have legalized cannabinoids for medical use. This is closely followed by CB2 receptors in second place.

Medical 98

Medical Specialization Marketing Leads 98

Pharmaceutical Technology

MAY 2, 2023

There are more than 20 marketed ICIs with approvals across a very wide spectrum of solid tumour indications. Marketed bispecific antibodies are largely bispecific T-cell engagers (BiTEs), which work by directing T-cells to antigen-expressing tumour cells. Cost-related unmet needs also scored highly.

Physicians 52

Physicians Marketing Patients Manufacturing 52

Cadensee

JANUARY 1, 2022

20:27 Obviously the US market is very interesting, why aren’t you creating a product for the German market? How would that be different from a young entrepreneur kind of doing this as his first job versus someone who had more experience in the market? So, they market it to everyone and we see a very unique type of population.

Marketing 52

Marketing Physicians Medical Healthcare 52

Pharmaceutical Technology

MARCH 17, 2023

These agreements have been particularly propelled by the recent rise in inflationary pressures and pharmaceutical market instability, pushing healthcare systems to find new ways to reduce risks associated with new drugs. Thus, a higher risk score reflects a more hostile market access environment and drug launch in a geographical area.

Marketing 102

Marketing Pharma Pharmaceutical Healthcare 102